Stocks › LLY
Eli Lilly and Co LLY
US equityMarket cap rank #13
$1,354.00 −$10.73 (-0.79%)
Market closed · Nov 7, 9:50 pm ET · Last extended-hours $1,357.00 +0.22%
Open$1,350.45
Prev close$1,364.73
Day range$1,333.22 – $1,377.28
Volume3.81M
Market cap$1.27T
P/E (TTM)43.9
Dividend yield0.49%
Analyst view
ConsensusBuy
Analysts24
Average target$1,511.30+11.6% vs. price
- Buy 92%
- Hold 4%
- Sell 4%
Low $940.00Now $1,354.00Avg $1,511.30High $1,650.00
Recent rating changes
The last 20 actions on file set price targets from $1,400.00 to $1,650.00, averaging $1,582.90.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 5 Nov 2026 | BofA Securities | BUY | $1,557.00 |
| 2 Nov 2026 | BMO Capital | BUY | $1,650.00 |
| 2 Nov 2026 | Leerink Partners | BUY | $1,508.00 |
| 1 Nov 2026 | Cantor Fitzgerald | BUY | $1,600.00 |
| 30 Oct 2026 | Argus Research | BUY | $1,550.00 |
| 30 Oct 2026 | UBS | BUY | $1,625.00 |
| 30 Oct 2026 | Truist Financial | BUY | $1,612.00 |
| 30 Oct 2026 | Freedom Capital Markets | BUY | $1,600.00 |
| 30 Oct 2026 | Scotiabank | BUY | $1,605.00 |
| 30 Oct 2026 | Morgan Stanley | BUY | $1,596.00 |
| 30 Oct 2026 | BMO Capital | BUY | $1,650.00 |
| 30 Oct 2026 | Citi | BUY | $1,650.00 |
| 30 Oct 2026 | Goldman Sachs | BUY | $1,573.00 |
| 30 Oct 2026 | J.P. Morgan | BUY | $1,650.00 |
| 29 Oct 2026 | Wells Fargo | BUY | $1,500.00 |
| 29 Oct 2026 | UBS | BUY | $1,625.00 |
| 29 Oct 2026 | BofA Securities | BUY | $1,497.00 |
| 29 Oct 2026 | Jefferies | BUY | $1,610.00 |
| 29 Oct 2026 | Barclays | BUY | $1,400.00 |
| 29 Oct 2026 | RBC Capital | BUY | $1,600.00 |
No comments yet — be the first to weigh in on LLY.
Sign in to join the discussion.